Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Cancer, Psychosocial Functioning, Treatment Side Effects, Cachexia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of Body Composition, Psychosocial Factors, and Drug-Related Problems in Relation to Clinical Progression in Cancer Patients Receiving Immune Checkpoint Inhibitors
Overview
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Primary outcome measures
- Body composition evaluation [Time frame: Patient recruitment is planned to occur over a 6-month period. Each participant will be followed for a maximum duration of 6 months from the initiation of immunotherapy.]
Secondary outcome measures (2)
- Cachexia and psychosocial factors evaluation [Time frame: Throughout 6 months of follow-up.]
- Drug Related Problems [Time frame: Throughout 6 months of follow-up.]
Eligibility criteria
Inclusion criteria
- Aged 18 years or older
- Having undergone a CT scan (at the L3 level) prior to treatment
- No severe mental disorder and able to communicate effectively
- Provided written informed consent
Exclusion criteria
- Did not provide written informed consent
- Patients deemed unsuitable by the physician
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Turkey (Türkiye) · 1 center
- Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy — Ankara
Identifiers
NCT: NCT07130981 · SBA 25/672